Rafferty Asset Management, LLC
Position in NTLA — Intellia Therapeutics, Inc.
CIK 1389426
New York, NY
Position in NTLA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,560,897
+$624,200 QoQ
Shares Held
199,758
-7.3% QoQ
Ownership
0.143%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTLA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Rafferty Asset Management, LLC holds $408,627,656 across 136 Biotechnology names. NTLA ranks #62 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
54,572 | $24,368,580 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
29,589 | $22,861,644 | |
| 3 | INSM |
INSMED Inc
|
116,069 | $18,979,602 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
50,553 | $16,726,471 | |
| 5 | APLS |
Apellis Pharmaceuticals, Inc.
|
180,471 | $7,260,348 | |
| 6 | MRNA |
Moderna, Inc.
|
114,194 | $5,801,055 | |
| 7 | INCY |
Incyte Corp
|
60,565 | $5,700,377 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
10,452 | $5,471,308 |
All Filings in NTLA
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,560,897 | 199,758 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,936,697 | 215,428 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,161,981 | 183,091 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,208,078 | 128,793 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,280,454 | 180,092 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,975,678 | 255,204 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $5,251,511 | 255,548 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $5,040,244 | 225,212 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $8,901,163 | 323,561 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $10,031,149 | 328,998 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $7,940,572 | 251,125 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $8,497,247 | 208,368 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $7,878,430 | 211,388 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $8,180,448 | 234,464 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $7,255,717 | 129,659 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,999,967 | 115,919 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $6,520,025 | 89,721 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $5,658,256 | 47,854 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $2,601,302 | 19,391 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $4,951,531 | 30,582 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $4,081,368 | 50,855 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $952,217 | 17,504 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,623,500 | 81,665 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $511,752 | 24,346 | Shares | Sole | 2020-08-07 | |
| No filing history on record for this holder in this stock. | ||||||